المؤلفون: Salvatore Pisconti, Vittorio Gebbia, Michele Aieta, Erica Palesandro, Emanuele Naglieri, Donatello Gasparro, Nicolò Borsellino, Antonio Maestri, Anna Crispo, A. Farnesi, Francesco Grillone, Lucia Bonomi, Gaetano Facchini, Giovanni Re, Giacomo Cartenì, Rocco De Vivo, Sarah Scagliarini, Giuseppe Di Lorenzo, Umberto Basso, Ferdinando De Vita, Enrico Ricevuto, Gelsomina Iovane, Claudio Sini, Maria Giuseppa Vitale, Luca Galli, Carla Cavaliere, Sabrina Rossetti, Carmine D'Aniello, Michele De Tursi, Carlo Buonerba, Chiara Ciccarese, Roberto Iacovelli, Claudio Scavelli, Ugo De Giorgi, Paolo Marchetti, Vincenza Conteduca, Leonardo La Torre, Massimiliano Berretta

المساهمون: Facchini, G., Rossetti, S., Berretta, M., Cavaliere, C., Scagliarini, S., Vitale, M. G., Ciccarese, C., Di Lorenzo, G., Palesandro, E., Conteduca, V., Basso, U., Naglieri, E., Farnesi, A., Aieta, M., Borsellino, N., La Torre, L., Iovane, G., Bonomi, L., Gasparro, D., Ricevuto, E., De Tursi, M., De Vivo, R., Lo Re, G., Grillone, F., Marchetti, P., De Vita, F., Scavelli, C., Sini, C., Pisconti, S., Crispo, A., Gebbia, V., Maestri, A., Galli, L., De Giorgi, U., Iacovelli, R., Buonerba, C., Carteni, G., D'Aniello, C.

المصدر: Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-11 (2019)
Journal of Translational Medicine
Università degli studi di Foggia-IRIS

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Multivariate analysis, Axitinib, Metastatic, Renal cancer, Sunitinib, Treatment, medicine.medical_treatment, Population, lcsh:Medicine, Kaplan-Meier Estimate, Disease-Free Survival, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, Neoplasm Metastasis, education, Adverse effect, Metastatic renal cell cancer, Carcinoma, Renal Cell, Aged, Aged, 80 and over, Second-line therapy, education.field_of_study, business.industry, Research, lcsh:R, General Medicine, Middle Aged, Kidney Neoplasms, Nephrectomy, 030104 developmental biology, 030220 oncology & carcinogenesis, Multivariate Analysis, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12acb662f5d5d700c929cd93d0d7e2fTest
http://link.springer.com/article/10.1186/s12967-019-2047-4Test

المؤلفون: Francesco Grillone, Giuseppe Procopio, Andrea Sbrana, Delia De Lisi, Daniele Santini, Sandro Pignata, Francesca Vignani, Sebastiano Buti, Emanuele Naglieri, Laura Attademo, Marco Maruzzo, Marco Stellato, Rocco De Vivo, Melissa Bersanelli, Davide Bimbatti, Francesco Pantano, Elena Verzoni, Mariella Sorarù, Ugo De Giorgi, Giuseppe Fornarini, Claudia Mucciarini, Chiara Casadei, Giuseppe Di Lorenzo, Enrico Mini

المصدر: American journal of clinical oncology. 44(3)

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Cabozantinib, Pyridines, Programmed Cell Death 1 Receptor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Anilides, 030212 general & internal medicine, Progression-free survival, Everolimus, Adverse effect, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Aged, Retrospective Studies, business.industry, Hazard ratio, Retrospective cohort study, Middle Aged, medicine.disease, cabozantinib, immune-oncology, immunotherapy, renal cell carcinoma, therapeutic sequence, Carcinoma, Renal Cell, Disease Progression, Female, Italy, Kidney Neoplasms, Nivolumab, Treatment Outcome, Confidence interval, Oncology, chemistry, 030220 oncology & carcinogenesis, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a347a85f9d38514807dad0da00368341Test
https://pubmed.ncbi.nlm.nih.gov/33617179Test

المؤلفون: Nicoletta Staropoli, Pierfrancesco Tassone, Vito Barbieri, Angela Salvino, Pierosandro Tagliaferri, Domenico Ciliberto, Teresa Del Giudice, Francesco Grillone, Antonio Russo, Maria Cucè, Eleonora Iuliano

المساهمون: Staropoli, Nicoletta, Ciliberto, Domenico, Del Giudice, Teresa, Iuliano, Eleonora, Cucè, Maria, Grillone, Francesco, Salvino, Angela, Barbieri, Vito, Russo, Antonio, Tassone, Pierfrancesco, Tagliaferri, Pierosandro

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Settore MED/06 - Oncologia Medica, Poly (ADP-Ribose) Polymerase-1, Poly(ADP-ribose) Polymerase Inhibitors, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Ovarian cancer, Internal medicine, medicine, Humans, Meta-analysi, Progression-free survival, Adverse effect, Ovarian Neoplasms, business.industry, Hazard ratio, Hematology, Prognosis, Clinical trial, 030104 developmental biology, PARP inhibitor, 030220 oncology & carcinogenesis, Meta-analysis, Relative risk, Cohort, Female, Randomized clinical trial, Maintenance therapy, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce94b6b66d1bf4982c1662dd47dbf8acTest
http://hdl.handle.net/10447/298741Test

المؤلفون: Sandro Pignata, Chiara Della Pepa, Anna Crispo, Michele De Tursi, Maria Maddalena Laterza, A. Farnesi, Sabrina Chiara Cecere, Gelsomina Iovane, Emanuele Naglieri, Gaetano Facchini, Marilena Di Napoli, Giuseppe Quarto, Luca Galli, Lorenzo Calvetti, Sabrina Rossetti, Francesco Grillone, Salvatore Pisconti, Giacomo Cartenì, Carmine D'Aniello, Carla Cavaliere, Gennaro Ciliberto, Maria Giuseppa Vitale, Sisto Perdonà, Rocco De Vivo, Ferdinando De Vita, Enrico Ricevuto, Raffaele Piscitelli, Alfonso Amore, Ugo De Giorgi, Piera Maiolino, Vincenza Conteduca, Paolo Muto, Massimiliano Berretta

المساهمون: D'Aniello, C, Vitale, Mg, Farnesi, A, Calvetti, L, Laterza, Mm, Cavaliere, C, Della Pepa, C, Conteduca, V, Crispo, A, DE VITA, Ferdinando, Grillone, F, Ricevuto, E, De Tursi, M, De Vivo, R, Di Napoli, M, Cecere, Sc, Iovane, G, Amore, A, Piscitelli, R, Quarto, G, Pisconti, S, Ciliberto, G, Maiolino, P, Muto, P, Perdonà, S, Berretta, M, Naglieri, E, Galli, L, Cartenì, G, De Giorgi, U, Pignata, S, Facchini, G, Rossetti, S.

المصدر: Frontiers in Pharmacology, Vol 7 (2016)
Frontiers in Pharmacology

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Axitinib, Metastatic renal cancer, First-line treatment, urologic and male genital diseases, Gastroenterology, MPFS, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, mRCC, first-line treatment, axitinib, real-life patient, mPFS, medicine, Clinical endpoint, Pharmacology (medical), Progression-free survival, Adverse effect, Original Research, Pharmacology, mRCC, Real-life patient, business.industry, Sunitinib, lcsh:RM1-950, Significant difference, Axitinib, First-line treatment, MPFS, mRCC, Real-life patient, medicine.disease, Surgery, lcsh:Therapeutics. Pharmacology, 030104 developmental biology, 030220 oncology & carcinogenesis, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20faa5d5d330b179d09f5db3ce0c1bffTest
https://doi.org/10.3389/fphar.2016.00331Test